The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection

Saved in:
Bibliographic Details
Published inLeukemia Vol. 34; no. 10; pp. 2790 - 2793
Main Authors Lai, Peilong, Chen, Xiaomei, Qin, Le, Jiang, Zhiwu, Luo, Chenwei, Huang, Xin, Wu, Sujing, Ling, Wei, Wang, Yulian, Wang, Jinghua, Deng, Chenxin, Huang, Lisi, Zeng, Lingji, Lu, Zesheng, Zhong, Liye, Liao, Pengjun, Li, Minming, Chen, Dongmei, Geng, Suxia, Wu, Ping, Tang, Zhaoyang, Pei, Duanqing, Du, Xin, Li, Peng, Weng, Jianyu
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.10.2020
Nature Publishing Group
Subjects
14/5
631/250/251
64/60
692/700/565/251
Animals
Cancer Research
Cell therapy
Critical Care Medicine
Development and progression
Disease Models, Animal
Female
Health aspects
Hematology
Hepatitis B
Hepatitis B - complications
Hepatitis B - diagnosis
Hepatitis B - immunology
Hepatitis B - virology
Hepatitis B virus - immunology
Humans
Immunotherapy, Adoptive - adverse effects
Immunotherapy, Adoptive - methods
Intensive
Internal Medicine
Letter
Lymphocytes
Lymphocytes T
Male
Medicine
Medicine & Public Health
Mice
Middle Aged
Oncology
Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology
Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen
T cells
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
Treatment Outcome
Xenograft Model Antitumor Assays
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0887-6924
1476-5551
1476-5551
DOI:10.1038/s41375-020-0952-4